[HTML][HTML] STAT3 as a potential therapeutic target in triple negative breast cancer: a systematic review
Triple negative breast cancer (TNBC), which is typically lack of expression of estrogen
receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor 2 …
receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor 2 …
Immune checkpoints in the tumor microenvironment
Interactions between immune checkpoints (ICs) and their ligands negatively regulate T cell
activation pathways involved in physiological immune responses against specific antigens …
activation pathways involved in physiological immune responses against specific antigens …
STAT family of transcription factors in breast cancer: Pathogenesis and therapeutic opportunities and challenges
GL Wong, SG Manore, DL Doheny, HW Lo - Seminars in cancer biology, 2022 - Elsevier
Breast cancer is the most commonly diagnosed cancer and second-leading cause of cancer
deaths in women. Breast cancer stem cells (BCSCs) promote metastasis and therapeutic …
deaths in women. Breast cancer stem cells (BCSCs) promote metastasis and therapeutic …
Lipopolysaccharide facilitates immune escape of hepatocellular carcinoma cells via m6A modification of lncRNA MIR155HG to upregulate PD-L1 expression
L Peng, B Pan, X Zhang, Z Wang, J Qiu, X Wang… - Cell biology and …, 2022 - Springer
Recent studies have suggested that the initiation and progression of hepatocellular
carcinoma (HCC) are closely associated with lipopolysaccharide (LPS) of intestinal bacteria …
carcinoma (HCC) are closely associated with lipopolysaccharide (LPS) of intestinal bacteria …
[HTML][HTML] NLRP3 inflammasome upregulates PD-L1 expression and contributes to immune suppression in lymphoma
F Lu, Y Zhao, Y Pang, M Ji, Y Sun, H Wang, J Zou… - Cancer letters, 2021 - Elsevier
The NLRP3 inflammasome plays a pro-tumorigenic role in various malignancies. However,
its potential role in lymphomagenesis remains unclear. In this study, we identified an …
its potential role in lymphomagenesis remains unclear. In this study, we identified an …
[HTML][HTML] Enhancement of PD-L1-attenuated CAR-T cell function through breast cancer-associated fibroblasts-derived IL-6 signaling via STAT3/AKT pathways
N Chuangchot, P Jamjuntra, S Yangngam… - Breast Cancer …, 2023 - Springer
Abstract Background Carcinoma-associated fibroblasts (CAFs) play a critical role in cancer
progression and immune cell modulation. In this study, it was aimed to evaluate the roles of …
progression and immune cell modulation. In this study, it was aimed to evaluate the roles of …
Combination therapy with nivolumab (anti-PD-1 monoclonal antibody): A new era in tumor immunotherapy
BA Kiasari, A Abbasi, NG Darestani, N Adabi… - International …, 2022 - Elsevier
Immune checkpoint inhibitors (ICIs) targeting programmed cell death-1 (PD-1 or CD279)
have noticeably improved the treatment landscape of advanced cancer patients. Nivolumab …
have noticeably improved the treatment landscape of advanced cancer patients. Nivolumab …
[HTML][HTML] Breast Cancer Cells and PD-1/PD-L1 Blockade Upregulate the Expression of PD-1, CTLA-4, TIM-3 and LAG-3 Immune Checkpoints in CD4+ T Cells
Triple negative breast cancer (TNBC) is the most aggressive breast cancer subtype, and it
exhibits resistance to common breast cancer therapies. Immune checkpoint inhibitors (ICIs) …
exhibits resistance to common breast cancer therapies. Immune checkpoint inhibitors (ICIs) …
[HTML][HTML] STAT3 signaling in breast cancer: multicellular actions and therapeutic potential
Simple Summary Many signaling pathways are overactive in breast cancer, and among
them is the STAT3 signaling pathway. STAT3 is activated by secreted factors within the …
them is the STAT3 signaling pathway. STAT3 is activated by secreted factors within the …
[HTML][HTML] STAT3 activity promotes programmed-death ligand 1 expression and suppresses immune responses in breast cancer
I Zerdes, M Wallerius, EG Sifakis, T Wallmann, S Betts… - Cancers, 2019 - mdpi.com
Signal transducer and activator of transcription 3 (STAT3) is an oncogene and multifaceted
transcription factor involved in multiple cellular functions. Its role in modifying anti-tumor …
transcription factor involved in multiple cellular functions. Its role in modifying anti-tumor …